The expression of TTYH3, another identified marker, has been associated with poor prognosis and poor response to immunotherapy in lung cancer [39] with high level of expression associated with immune cell infiltration, specifically macrophages and T-reg cells [39–48]. Here, TTYH3 is linked to lung carcinoma.